Skip to content
Brand AI

PharmaMar

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    FDA grants accelerated approval for Zepzelca

    The FDA granted accelerated approval for Zepzelca (lurbinectedin) to treat adults with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy. Jazz Pharmaceuticals and PharmaMar secured the approval.

    Source